Last reviewed · How we verify

NCT04225455: DEXFLY2

The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes

Active, enrolled Last updated 24 November 2025
What this trial tests

trial testing Glucose monitoring in Insulin Dependent Diabetes in 17 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 December 2019
Primary endpoint
1 October 2025
30 December 2025

Quick facts

Lead sponsorUniversity of Surrey
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment17
Start date5 December 2019
Primary completion1 October 2025
Estimated completion30 December 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Surrey

Who can join

Adults 18 to 75, any sex, with Insulin Dependent Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare glucose control achieved by using real time continuous glucose monitoring (CGMS) Dexcom G6® in combination with self-monitored blood glucose during flight and also with free living in pilots.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Glucose monitoring

Trials testing the same drug.

Other recruiting trials for Insulin Dependent Diabetes

Currently open trials in the same condition.

Other University of Surrey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04225455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing